Fig. 8 | Scientific Reports

Fig. 8

From: Development and evaluation of cepharanthine-β-cyclodextrin inclusion complex oral tablets for prevention and treatment of COVID-19 lung injury

Fig. 8

Mechanistic evaluation in cells. (A) Cytotoxicity assessment and cell viability of MH-S cells treated with the CEP–β-CD inclusion complex. (B) CEP–-β-CD inclusion complex inhibits the LPS-induced secretion of inflammatory cytokines. n = 5, \(\bar{\text{x}}+\text{s}\), **** P < 0.0001, *** P < 0.001 vs. the model group.

Back to article page